The plasma level of HSP90α in patients with malignant melanoma was significantly higher than that in healthy subjects, and the AUCs value was higher than lactate dehydrogenase (LDH), with higher sensitivity (76.7%) and predictive value (78.8%) (63). This evidence concerns the gene HSP90AA1 and melanoma.